Rite Aid Expands No-Charge COVID-19 Testing to 400 Drive-Through Locations
December 21 2020 - 9:00AM
Business Wire
Self-Swab Testing Capacity Increased by More
Than 30%
Rite Aid (NYSE: RAD) is further expanding its no-charge COVID-19
testing capabilities with 99 additional drive-through locations
opening on Tuesday, December 22 through its partnership with the
U.S. Department of Health and Human Services (HHS).
Rite Aid’s COVID-19 testing service will expand coast-to-coast,
with new locations in California, Nevada, Washington, Michigan,
Ohio, Pennsylvania, Virginia, New York, Connecticut, New Jersey,
Delaware, and Maryland.
Like Rite Aid’s existing drive-through testing sites, the new
locations will utilize simple self-swab nasal tests overseen by
Rite Aid pharmacists and will operate Monday through Friday 10 a.m.
- 8 p.m. and Saturday and Sunday 10 a.m. - 5 p.m. Rite Aid’s
COVID-19 nasal tests are available for all individuals 13 years of
age or older, regardless if they are experiencing virus symptoms,
in accordance with the Centers for Disease Control and Prevention
(CDC) guidance.
At all testing locations, patients are required to provide
government issued identification and need to pre-register online at
www.riteaid.com in order to schedule a time slot for testing. For
individuals under 18 to get screened and tested, parents or legal
guardians must create Baseline COVID-19 accounts using the minor’s
email account, provide consent, show their government issued
identification, and must accompany their children to the
appointment and supervise them during the test.
Now operating 400 total testing sites across 16 states, Rite Aid
has adequate capacity to test symptomatic and asymptomatic
individuals 13 years and older who want to be tested. Online
appointments can be made by visiting www.riteaid.com. A complete
list of Rite Aid's COVID-19 testing sites can also be found at
www.riteaid.com.
Rite Aid partners with Verily and its Baseline COVID-19 Testing
Program to provide screening, scheduling and return of results to
participants for Rite Aid testing sites.
BioReference Laboratories provides COVID-19 laboratory
testing.
Clinical oversight for the COVID-19 testing program is provided
by PWNHealth, a national clinician network that enables safe and
easy access to diagnostic testing.
Rite Aid will continue to provide regular updates on the
company's progress with COVID-19 testing.
About Rite Aid Corporation
Rite Aid Corporation is on the front lines of delivering
healthcare services and retail products to more than 1.6 million
Americans daily. Our pharmacists are uniquely positioned to engage
with customers and improve their health outcomes. We provide an
array of whole being health products and services for the entire
family through over 2,400 retail pharmacy locations across 17
states. Through Elixir, we provide pharmacy benefits and services
to approximately 4 million members nationwide. For more
information, www.riteaid.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201221005022/en/
MEDIA: Chris Savarese 717-975-5718
christopher.savarese@riteaid.com
Rite Aid (NYSE:RAD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Rite Aid (NYSE:RAD)
Historical Stock Chart
From Apr 2023 to Apr 2024